本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Auris Medical Holding AG

3.05
0.0000
成交量:- -
成交額:- -
市值:3,918.79萬
市盈率:-1.98
高:3.05
開:3.05
低:3.05
收:3.05
52周最高:6.60
52周最低:0.7255
股本:1,286.96萬
流通股本:1,219.92萬
量比:- -
換手率:- -
股息:- -
股息率:- -
每股收益(TTM):-1.5411
每股收益(LYR):-1.5411
淨資產收益率:-71.91%
總資產收益率:-21.99%
市淨率:1.86
市盈率(LYR):-1.98

資料載入中...

2021/05/21

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/03/31

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2021/03/31

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/15

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/12/07

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/10/21

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/06

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/17

財報披露

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/08/20

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/06/19

SEC問詢函

CORRESP [Cover] - Correspondence
2020/05/08

SEC問詢函

CORRESP [Cover] - Correspondence
2020/04/29

招股説明書

Registration statement for certain foreign private issuers
2020/04/16

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/23

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/04

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/15

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/12

超過5%披露

[Amend] General statement of acquisition of beneficial ownership